Guide

    Key Elements of an AI Governance Program in Healthcare

    A healthcare AI governance program is a formalized, organization-wide system of rules, processes, roles, and technical controls governing how AI is selected, approved, deployed, monitored, and retired, covering both internally developed and third-party tools. The gap is stark: 71% of U.S. hospitals now use predictive AI integrated into their EHRs, but only 29% have implemented and enforced policies covering AI model inventory, lineage, and sign-offs.

    Key takeaways

    • Healthcare AI governance combines people, policies, processes, and technology to keep AI safe and HIPAA-compliant
    • Enforcement is no longer hypothetical: the DOJ's $1.43M penalty against Troy Health for AI-driven Medicare fraud and the Texas AG's settlement with Pieces Technologies over deceptive hallucination metrics both landed in healthcare
    • Shadow AI compounds the risk: 71% of healthcare workers use personal AI accounts for work, and 81% of data policy violations involve PHI
    • Policies only work when enforced at runtime, documentation alone doesn't prevent violations
    • Programs need scheduled reviews tied to regulatory updates and new deployments, not one-time setup

    Element 1: Governance structure and accountability

    A standing AI governance committee with clinical, IT, security, compliance, and legal representation, plus a named owner with authority. Every AI system in an inventory with lineage and sign-offs; without this, the program governs only the AI it knows about.

    Element 2: AI use policies, risk classification, and regulatory compliance

    Policies per use case and risk tier (clinical decision support vs. administrative automation), mapped to HIPAA, FDA expectations for clinical AI, and state law. Risk classification determines review depth, human-oversight requirements, and monitoring intensity.

    Element 3: Data privacy, PHI protection, and security controls

    PHI detection and redaction in the AI request path; least-privilege access for users, applications, and agents; vendor AI brought under the same controls. This is where shadow AI does the most damage, and where runtime enforcement does the most good, blocking PHI exposure at the moment of use.

    Element 4: AI lifecycle management and continuous monitoring

    From approval through deployment, drift monitoring, vendor-update review, and retirement. Per-interaction audit trails (model, version, policy results, lineage) make behavior explainable when clinicians, compliance, or regulators ask.

    Element 5: Ethical AI, algorithmic transparency, and bias mitigation

    Bias assessment proportionate to clinical impact, transparency about AI involvement in care-adjacent decisions, and review checkpoints where stakes warrant a human.

    What are the common gaps and mistakes?

    Inventory blindness (governing the known 60% of AI), paper-only policies, no agent-level controls, no scheduled review cadence, and vendor AI excluded from scope. The unifying fix is infrastructure: a runtime control plane, Trussed AI's model, that enforces PHI and usage policies in-line, covers third-party tools via proxy, and generates HIPAA-ready evidence automatically.

    Frequently Asked Questions

    Who should chair healthcare AI governance? A senior leader who bridges clinical and technical authority, commonly the CMIO or CHIO, with compliance and security as standing members.

    How do we govern AI embedded in our EHR and vendor systems? Inventory it explicitly, contract for transparency, and route what you can through runtime controls; embedded vendor AI is inside HIPAA scope whether or not you selected the model.

    How often should the program be reviewed? On a defined cadence (at least annually) plus event-driven reviews on regulatory change, new deployments, and incidents.

    Ready to govern your AI in production?